miR-125b-5p inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via targeting TXNRD1.

Shengni HuaYingyao QuanMeixiao ZhanHuaxin LiaoYong LiSheng-Ni Hua

Published in: Cancer cell international (2019)

These results demonstrated miR-125b-5p as a tumor suppressor in HCC through its inhibition of TXNRD1, thereby suggesting it as a potential target for the clinical treatment of HCC.

Keyphrases

cell proliferation
cell cycle
cancer therapy
pi k akt
drug delivery
replacement therapy